Leo Loughlin and Davide Schiavetti at Medmarc Webinar on Overcoming Unique Issues Regarding Trademark Searching and Filing for the Pharmaceutical Industry

Print PDF Icon
 | 2:00 pm ET

Partner Leo Loughlin and associate Davide Schiavetti will present a webinar titled "Overcoming Unique Issues Regarding Trademark Searching and Filing for the Pharmaceutical Industry" for Medmarc, the leading expert in the products liability risks facing medical technology and life sciences companies. The webinar will take place on Wednesday, April 24, 2024, at 2 pm ET. The event is free of charge and open to the public.

Trademarks in the pharmaceutical industry are important not only as part of a company’s intellectual property portfolio, but also as a matter of public health, and obtaining a trademark registration in the pharmaceutical industry raises unique issues and considerations that need to be carefully navigated. When selecting a new product name, formulating a clearance strategy, and filing and prosecuting applications for marks, there are processes and techniques that help avoid and, if necessary, overcome roadblocks from the Food & Drug Administration (FDA) and the U.S. Patent and Trademark Office (USPTO). Join us to learn how to efficiently make your selection, obtain clearance, and acquire a trademark registration in order to protect your pharmaceutical innovation.

Our 60-minute discussion will cover:

  • Initial steps in selecting pharma marks
  • Conducting the most comprehensive search possible, including searching the Orange Book and Pharma in use databases
  • Navigating proposed marks already on file at the FDA
  • Navigating naming issues at the FDA
  • Properly describing your trademark application for a new pharma product
  • Overcoming initial USPTO refusals to a pharma mark
  • Addressing possible challenges from third parties during publication
  • Unique issues with filing proof of use at the USPTO

This webinar is free and open to the public. To register, please click on RSVP above, or access the registration page here

Jump to Page

By using this site, you agree to our updated Privacy Policy and our Terms of Use.